Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma

NCT03463265 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma

Interventions

DRUG: nab-sirolimus
DRUG: nab-sirolimus + temozolomide
DRUG: nab-sirolimus + bevacizumab
DRUG: nab-sirolimus + lomustine
DRUG: nab-sirolimus + marizomib (MRZ)
DRUG: nab-sirolimus + temozolomide + radiotherapy

Sponsor

Aadi Bioscience, Inc.